Paper32069876
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.
Conte E and 6 others. Int J Mol Sci, 2020. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies. Papers, record 32069876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32069876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cachexia | Major topic |
| Ghrelin | Major topic |
| Muscular Atrophy | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Body Weight | |
| Cisplatin | |
| Disease Models, Animal | |
| Growth Hormone | |
| Humans | |
| Muscle, Skeletal |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant 2019 to Annamaria De Luca | AFM-Téléthon | PubMed |
Source PubMed
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12859139 | The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. | J Am Acad Audiol | 2003 | https://conductscience.org/library/papers/12859139 | PubMed |
| 2 | 17138655 | A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes. | Endocrinology | 2007 | https://conductscience.org/library/papers/17138655 | PubMed |
| 3 | 16323823 | GH-releasing peptides and bone. | J Endocrinol Invest | 2005 | https://conductscience.org/library/papers/16323823 | PubMed |
| 4 | 19030871 | Dissociation between force and maximal Na+, K +-ATPase activity in rat fast-twitch skeletal muscle with fatiguing in vitro stimulation. | Eur J Appl Physiol | 2009 | https://conductscience.org/library/papers/19030871 | PubMed |
| 5 | 15275881 | Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer. | J Am Coll Surg | 2004 | https://conductscience.org/library/papers/15275881 | PubMed |
| 6 | 31191250 | The Role of Ghrelin in Regulating Synaptic Function and Plasticity of Feeding-Associated Circuits. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31191250 | PubMed |
| 7 | 11959048 | GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. | Eur J Heart Fail | 2002 | https://conductscience.org/library/papers/11959048 | PubMed |
| 8 | 11988484 | CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. | Circ Res | 2002 | https://conductscience.org/library/papers/11988484 | PubMed |
| 9 | 19382238 | Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils. | J Neurosci Res | 2009 | https://conductscience.org/library/papers/19382238 | PubMed |
| 10 | 9139826 | Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. | Nature | 1997 | https://conductscience.org/library/papers/9139826 | PubMed |
| 11 | 25399825 | Development of novel activin-targeted therapeutics. | Mol Ther | 2015 | https://conductscience.org/library/papers/25399825 | PubMed |
| 12 | 30685982 | Cancer cachexia is defined by an ongoing loss of skeletal muscle mass. | Ann Palliat Med | 2019 | https://conductscience.org/library/papers/30685982 | PubMed |
| 13 | 17927165 | Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. | J Med Chem | 2007 | https://conductscience.org/library/papers/17927165 | PubMed |
| 14 | 24861054 | Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. | Mol Ther | 2014 | https://conductscience.org/library/papers/24861054 | PubMed |
| 15 | 22751283 | Reducing the toxicity of cancer therapy: recognizing needs, taking action. | Nat Rev Clin Oncol | 2012 | https://conductscience.org/library/papers/22751283 | PubMed |
| 16 | 28475119 | Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28475119 | PubMed |
| 17 | 29991992 | Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. | Eur J Transl Myol | 2018 | https://conductscience.org/library/papers/29991992 | PubMed |
| 18 | 15507538 | Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. | Am J Physiol Endocrinol Metab | 2005 | https://conductscience.org/library/papers/15507538 | PubMed |
| 19 | 21296615 | Definition and classification of cancer cachexia: an international consensus. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21296615 | PubMed |
| 20 | 24035652 | Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. | Biomed Pharmacother | 2013 | https://conductscience.org/library/papers/24035652 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866359 | Assessment of chemotherapy-associated sarcopenia using SARC-F and handgrip strength: a cross-sectional analysis. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42866359 | PubMed |
| 42852623 | Multi‑target mechanisms of paeoniflorin in inflammatory regulation: A network pharmacology (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42852623 | PubMed |
| 42675546 | Integrative Analysis Uncover the Effects and Multi-Omics Features of Thigh Muscle Fat Infiltration. | Aging Cell | 2026 | https://conductscience.org/library/papers/42675546 | PubMed |
| 42620938 | A review of soluble mediator and cytokine networks linking combination immunotherapy, tumor microenvironment remodeling and skeletal muscle dysfunction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42620938 | PubMed |
| 42477307 | Quercetin attenuates cisplatin-induced muscle atrophy via Hippo/YAP1 signaling pathway. | J Nat Med | 2026 | https://conductscience.org/library/papers/42477307 | PubMed |
| 42286673 | The cGAS-STING pathway contributes to cisplatin-induced skeletal muscle atrophy through altered proteostasis and myogenic signaling. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42286673 | PubMed |
| 42270688 | Arab gum coating enhances the bioavailability and therapeutic potential of nanoselenium in cisplatin-induced testicular toxicity. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270688 | PubMed |
| 41766234 | Silymarin alleviates cisplatin-induced cachexia via modulating tripartite motif containing 63 (TRIM63) and myogenin. | Indian J Pharmacol | 2026 | https://conductscience.org/library/papers/41766234 | PubMed |
| 41754182 | A Combination of Amaranth Protein Hydrolysate and Korean Mint Extract Ameliorates Cisplatin-Induced Nephrotoxicity and Cachexia in CT26 Tumor-Bearing BALB/c Mice. | Nutrients | 2026 | https://conductscience.org/library/papers/41754182 | PubMed |
| 41419070 | The effects of tissue inflammation on cancer cachexia. | Biochim Biophys Acta Mol Basis Dis | 2026 | https://conductscience.org/library/papers/41419070 | PubMed |
| 41301412 | Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301412 | PubMed |
| 41300501 | N-Acetylcysteine Prevents Skeletal Muscle Cisplatin-Induced Atrophy by Inducing Myogenic microRNAs and Maintaining the Redox Balance. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41300501 | PubMed |
| 41015627 | Plasma CAF22 and NfL reflect neuromuscular decline during cisplatin-based chemotherapy and radical cystectomy in muscle-invasive bladder cancer. | Int J Clin Oncol | 2025 | https://conductscience.org/library/papers/41015627 | PubMed |
| 40780194 | Vagal blockade of the brain-liver axis deters cancer-associated cachexia. | Cell | 2025 | https://conductscience.org/library/papers/40780194 | PubMed |
| 40745291 | 30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40745291 | PubMed |
| 40731936 | Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40731936 | PubMed |
| 40691041 | B0092 tumor-bearing mice are a new model for the study of cachexia in head and neck cancer. | Am J Physiol Cell Physiol | 2025 | https://conductscience.org/library/papers/40691041 | PubMed |
| 40552152 | Molecular pharmacokinetic mechanism of quercetin-encapsulated polymeric micelles in alleviating cisplatin-induced nephrotoxicity and enhancing antineoplastic effects. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40552152 | PubMed |
| 40487396 | Hochuekkito accelerates recovery from cisplatin induced-muscle atrophy accompanied by slow-twitch fiber-specific microRNA upregulation in mice. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40487396 | PubMed |
| 40386783 | Tumor microenvironment and immune-related myositis: addressing muscle wasting in cancer immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40386783 | PubMed |
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32069876
GET https://conductscience.org/api/papers/v1/32069876/references?page=2